CYTOKINES IN CHRONIC INFLAMMATORY ARTHRITIS .5. MUTUAL ANTAGONISM BETWEEN INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA ON HLA-DR EXPRESSION, PROLIFERATION, COLLAGENASE PRODUCTION, AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION BY RHEUMATOID-ARTHRITIS SYNOVIOCYTES

被引:204
作者
ALVAROGRACIA, JM [1 ]
ZVAIFLER, NJ [1 ]
FIRESTEIN, GS [1 ]
机构
[1] UNIV CALIF SAN DIEGO,DEPT MED,DIV RHEUMATOL,225 DICKINSON ST,H-811-G,SAN DIEGO,CA 92103
关键词
Cytokine; Interferon-gamma; Rheumatoid arthritis; Synoviocyte; Tumor necrosis factor-alpha;
D O I
10.1172/JCI114908
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The effects of a broad array of cytokines, individually and in combination, were determined on separate functions (proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor [GM-CSF] production) and phenotype (expression of class II MHC antigens) of cultured fibroblastlike RA synoviocytes. The following recombinant cytokines were used: IL-1beta, IL-2, IL-3, IL-4, IFN-gamma, tumor necrosis factor (TNF)-alpha, GM-CSF, and macrophage colony-stimulating factor (M-CSF). Only IFN-gamma induced HLA-DR (but not HLA-DQ) expression. TNF-alpha inhibited IFN-gamma-mediated HLA-DR expression (46.7±4.1% inhibition) and HLA-DR mRNA accumulation. This inhibitory effect was also observed in osteoarthritis synoviocytes. Only TNF-alpha and IL-1 increased synoviocyte proliferation (stimulation index 3.60±1.03 and 2.31±0.46, respectively). IFN-gamma (but none of the other cytokines) inhibited TNF-alpha-induced proliferation (70±14% inhibition) without affecting the activity of IL-1. Only IL-1beta and TNF-alpha induced collagenase production (from < 0.10 U/ml to 1.10±0.15 and 0.72±0.24, respectively). IFN-gamma decreased TNF-alpha-mediated collagenase production (69±19% inhibition) and GM-CSF production but had no effect on the action of IL-1. These data demonstrate mutual antagonism between IFN-gamma and TNF-alpha on fibroblast-like synoviocytes and suggest a novel homeostatic control mechanism that might be defective in RA where very little IFN-gamma is produced.
引用
收藏
页码:1790 / 1798
页数:9
相关论文
共 57 条
[31]  
JOHNSON WJ, 1989, J IMMUNOL, V143, P1614
[32]   COLLAGENASE PRODUCTION BY HUMAN SYNOVIAL TISSUES [J].
KRANE, SM .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1975, 256 (JUN13) :289-303
[33]  
KUMKUMIAN GK, 1989, J IMMUNOL, V143, P833
[34]   UP-REGULATION OF THE EXPRESSION OF SECRETORY COMPONENT AND HLA MOLECULES IN A HUMAN COLONIC CELL-LINE BY TUMOR NECROSIS FACTOR-ALPHA-INTERFERON AND FACTOR-GAMMA-INTERFERON [J].
KVALE, D ;
BRANDTZAEG, P ;
LOVHAUG, D .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (03) :351-357
[35]   ANCHORAGE-INDEPENDENT GROWTH OF SYNOVIOCYTES FROM ARTHRITIC AND NORMAL JOINTS - STIMULATION BY EXOGENOUS PLATELET-DERIVED GROWTH-FACTOR AND INHIBITION BY TRANSFORMING GROWTH FACTOR-BETA AND RETINOIDS [J].
LAFYATIS, R ;
REMMERS, EF ;
ROBERTS, AB ;
YOCUM, DE ;
SPORN, MB ;
WILDER, RL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1267-1276
[36]  
LAFYATIS R, 1989, J IMMUNOL, V143, P1142
[37]   EFFECTS OF TUMOR NECROSIS FACTOR ON THE INTERFERON-GAMMA-INDUCED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II ANTIGEN EXPRESSION BY HUMAN-ENDOTHELIAL CELLS [J].
LEEUWENBERG, JFM ;
VANDAMME, J ;
MEAGER, T ;
JEUNHOMME, TMAA ;
BUURMAN, WA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (09) :1469-1472
[38]   RESULTS OF A MULTICENTER PLACEBO-CONTROLLED DOUBLE-BLIND RANDOMIZED PHASE-III CLINICAL-STUDY OF TREATMENT OF RHEUMATOID-ARTHRITIS WITH RECOMBINANT INTERFERON-GAMMA [J].
LEMMEL, EM ;
BRACKERTZ, D ;
FRANKE, M ;
GAUS, W ;
HARTL, PW ;
MACHALKE, K ;
MIELKE, H ;
OBERT, HJ ;
PETER, HH ;
SIEPER, J ;
SPREKELER, R ;
STIERLE, H .
RHEUMATOLOGY INTERNATIONAL, 1988, 8 (02) :87-93
[39]   ULTRASTRUCTURAL CHARACTERIZATION OF MACROPHAGES (TYPE-A CELLS) IN THE SYNOVIAL LINING [J].
MAPP, PI ;
REVELL, PA .
RHEUMATOLOGY INTERNATIONAL, 1988, 8 (04) :171-176
[40]   INTERLEUKIN-1 LYMPHOCYTE CHEMOTACTIC ACTIVITY IN RHEUMATOID-ARTHRITIS SYNOVIAL-FLUID [J].
MIOSSEC, P ;
DINARELLO, CA ;
ZIFF, M .
ARTHRITIS AND RHEUMATISM, 1986, 29 (04) :461-470